Lord, Abbett & Co
MIRM icon

Lord, Abbett & Co’s Mirum Pharmaceuticals MIRM Stock Holding History

Lord, Abbett & Co’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$57M Buy
617,064
+37,081
+6% +$3.49M 0.19% 145
2025
Q4 		$45.8M Sell
579,983
-81,957
-12% -$5.88M 0.14% 177
2025
Q3 		$48.5M Sell
661,940
-109,206
-14% -$6.94M 0.14% 168
2025
Q2 		$39.2M Sell
771,146
-42,252
-5% -$1.88M 0.13% 192
2025
Q1 		$36.6M Buy
813,398
+31,044
+4% +$1.46M 0.13% 191
2024
Q4 		$32.4M Buy
782,354
+40,986
+6% +$1.71M 0.1% 240
2024
Q3 		$28.9M Buy
+741,368
New +$29.6M 0.09% 265

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Lord, Abbett & Co's MIRM Position: Q1 2026 in Review

Lord, Abbett & Co increased its Mirum Pharmaceuticals (MIRM) stake by 6.4% in Q1 2026, buying an estimated $3.49M and bringing the position to 617,064 shares worth $57M. The position accounts for 0.19% of the portfolio, ranked #145.

Lord, Abbett & Co first reported a position in MIRM in Q3 2024 and has held it in 7 quarters since. 311 funds tracked by Wall St. Rank hold MIRM as of Q1 2026.

  • Lord, Abbett & Co held 617,064 shares of Mirum Pharmaceuticals worth $57M as of Q1 2026.
  • Lord, Abbett & Co bought 37,081 Mirum Pharmaceuticals shares in Q1 2026, an estimated $3.49M.
  • Mirum Pharmaceuticals made up 0.19% of Lord, Abbett & Co's portfolio in Q1 2026, its #145 holding.
  • Lord, Abbett & Co first reported a position in Mirum Pharmaceuticals in Q3 2024 and has held it in 7 quarters since.
  • 311 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q1 2026.

Based on Lord, Abbett & Co's 13F filing for Q1 2026, filed 14 May 2026.